Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
F.
Taylor Noggle, C.
Randall Clark & Jack
De Ruiter. (1991) Liquid Chromatographic and Spectral Methods for the Differentiation of 3,4-Methylenedioxymethamphetamine (MDMA) from Regioisomeric Phenethylamines. Journal of Liquid Chromatography 14:10, pages 1913-1928.
Read now
Read now
C.
Randall Clark, AllenK. Valaer & WilliamR. Ravis. (1990) Liquid Chromatographic Determination of N-Hydroxy-3,4-Methylenedioxyamphetamine and Metabolite in Plasma. Journal of Liquid Chromatography 13:7, pages 1375-1385.
Read now
Read now
Ernest Hodgson & Richard M. Philpot. (1975) Interaction of Methylenedioxyphenyl (1,3-Benzodioxole) Compounds with Enzymes and Their Effects on Mammals. Drug Metabolism Reviews 3:1, pages 231-301.
Read now
Read now
J.
Fred E. Shick & DavidE. Smith. (1972) The Illicit Use of the Psychotomimetic Amphetamines With Special Reference to STP (DOM) Toxicity. Journal of Psychedelic Drugs 5:2, pages 131-138.
Read now
Read now
Articles from other publishers (25)
Yan Ding, Xuefei Hou, Li Chen, Hua Zhou, Yanju Gong, Liqun Dai & Yu Zheng. (2016) Heme oxygenase-1 dependant pathway contributes to protection by tetramethylpyrazine against chronic hypoxic injury on medulla oblongata in rats. Journal of the Neurological Sciences 361, pages 101-111.
Crossref
Crossref
Steven Karch & Olaf Drummer. 2015. Karch's Pathology of Drug Abuse, Fifth Edition. Karch's Pathology of Drug Abuse, Fifth Edition
365
428
.
B Costall, R J Naylor & R M Pinder. (1974) Design of agents for stimulation of neostriatal dopaminergic mechanisms. Journal of Pharmacy and Pharmacology 26:10, pages 753-762.
Crossref
Crossref
D M Paton. (1975)
Effect of amphetamine, 3,4-methylenedioxyamphetamine,
p
-methoxyamphetamine and related amphetamines on uptake of metaraminol and efflux of noradrenaline in adrenergic nerves of rabbit atria
. Journal of Pharmacy and Pharmacology 27:5, pages 361-362.
Crossref
Crossref
Rafael de la Torre, Mag?? Farr??M??nica Navarro, Roberta Pacifici, Piergiorgio Zuccaro & Simona Pichini. (2004) Clinical Pharmacokinetics of Amfetamine and Related Substances. Clinical Pharmacokinetics 43:3, pages 157-185.
Crossref
Crossref
Terrence J. Monks, Fengju Bai, R. Timothy Miller & Serrine S. Lau. 2001. Biological Reactive Intermediates VI. Biological Reactive Intermediates VI
397
406
.
K.M Hegadoren, G.B Baker & M Bourin. (1999) 3,4-Methylenedioxy analogues of amphetamine: Defining the risks to humans. Neuroscience & Biobehavioral Reviews 23:4, pages 539-553.
Crossref
Crossref
Joseph A. Barone & Kenneth M. ShermockJRJR. (2016) Designer Drugs of Abuse. Journal of Pharmacy Practice 10:4, pages 292-300.
Crossref
Crossref
Karla A. Moore, Ashraf Mozayani, Marcella F. Fierro & Alphonse Poklis. (1996) Distribution of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) stereoisomers in a fatal poisoning. Forensic Science International 83:2, pages 111-119.
Crossref
Crossref
K. M. Hegadoren, M. T. Martin-Iverson & G. B. Baker. (1995) Comparative behavioural and neurochemical studies with a psychomotor stimulant, an hallucinogen and 3,4-methylenedioxy analogues of amphetamine. Psychopharmacology 118:3, pages 295-304.
Crossref
Crossref
Alphonse Poklis, Robert L. Fitzgerald, Karen V. Hall & Joseph J. Saady. (1993) EMIT-d.a.u. monoclonal amphetamine/methamphetamine assay. II. Detection of methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA). Forensic Science International 59:1, pages 63-70.
Crossref
Crossref
M.Y. Yousif, R.L. Fitzgerald, N. Narasimhachari, J.A. Rosecrans, R.V. Blanke & R.A. Glennon. (1990) Identification of metabolites of 3,4-methylenedioxymethamphetamine in rats. Drug and Alcohol Dependence 26:2, pages 127-135.
Crossref
Crossref
Cynthia K. Aaron. (1990) Sympathomimetics. Emergency Medicine Clinics of North America 8:3, pages 513-526.
Crossref
Crossref
William H. Soine. (2006) Clandestine drug synthesis. Medicinal Research Reviews 6:1, pages 41-74.
Crossref
Crossref
G. Ricaurte, G. Bryan, L. Strauss, L. Seiden & C. Schuster. (1985) Hallucinogenic Amphetamine Selectively Destroys Brain Serotonin Nerve Terminals. Science 229:4717, pages 986-988.
Crossref
Crossref
L. E. Hollister. 1982. Psychotropic Agents. Psychotropic Agents
31
44
.
David E. Nichols. (1981) Structure-Activity Relationships of Phenethylamine Hallucinogens. Journal of Pharmaceutical Sciences 70:8, pages 839-849.
Crossref
Crossref
D.B. Vaupel, M. Nozaki, W.R. Martin, L.D. Bright & E.C. Morton. (1979) The inhibition of food intake in the dog by LSD, mescaline, psilocin, -amphetamine and phenylisopropylamine derivatives. Life Sciences 24:26, pages 2427-2431.
Crossref
Crossref
Alphonse PoklisM. A. MackellW. K. Drake. (1979) Fatal Intoxication from 3,4-Methylenedioxyamphetamine. Journal of Forensic Sciences 24:1, pages 10791J.
Crossref
Crossref
W.R. Martin, D.B. Vaupel, M. Nozaki & L.D. Bright. (1978) The identification of LSD-like hallucinogens using the chronic spinal dog. Drug and Alcohol Dependence 3:2, pages 113-123.
Crossref
Crossref
Gerald M. Marquardt, Victor DiStefano & Lydia L. Ling. 1978. The Psychopharmacology of Hallucinogens. The Psychopharmacology of Hallucinogens
84
104
.
Leo E. Hollister. 1978. Stimulants. Stimulants
389
424
.
Masako Nozaki, Donald B. Vaupel & William R. Martin. (1977) A pharmacologic comparison of 3,4-methylenedioxyamphetamine and LSD in the chronic spinal dog. European Journal of Pharmacology 46:4, pages 339-349.
Crossref
Crossref
W. R. Martin & J. W. Sloan. 1977. Drug Addiction II. Drug Addiction II
305
368
.
Roland R. Griffiths, Gail Winger, Joseph V. Brady & Jack D. Snell. (1976) Comparison of behavior maintained by infusions of eight phenylethylamines in baboons. Psychopharmacology 50:3, pages 251-258.
Crossref
Crossref